Who
Troy Wichterman
Chief Financial Officer
Company insider
Files Form 4 as: Chief Financial Officer, BioLife Solutions.
In numbers
- Trades disclosed
- 115
- Buys
- 0
- Sells
- 63
- Bought
- $0
- Sold
- $2.5M
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 30 Nov 2021
- Last trade
- 6 Oct 2026
- Last filed
- 8 Oct 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 6 Oct 2026filed 8 Oct 2026 | BioLife SolutionsMedical Devices | SEC FORM 4 Code A | —76,204 | filing |
| 6 Oct 2026filed 8 Oct 2026 | BioLife SolutionsMedical Devices | SEC FORM 4 Code A | —62,300 | filing |
| 6 Oct 2026filed 8 Oct 2026 | BioLife SolutionsMedical Devices | SEC FORM 4 Code F | $3.7M95,933 at $38.61 | filing |
| 6 Oct 2026filed 8 Oct 2026 | BioLife SolutionsMedical Devices | SEC FORM 4 Code D | —256,000 | filing |
| 18 Sep 2026filed 22 Sep 2026 | BioLife SolutionsMedical Devices | SEC FORM 4 Code F | $34K937 at $36.69 | filing |
| 18 Sep 2026filed 22 Sep 2026 | BioLife SolutionsMedical Devices | SEC FORM 4 Code F | $34K937 at $36.69 | filing |
| 8 Sep 2026filed 10 Sep 2026 | BioLife SolutionsMedical Devices | SEC FORM 4 Code F | $36K1,026 at $35.38 | filing |
| 8 Sep 2026filed 10 Sep 2026 | BioLife SolutionsMedical Devices | SEC FORM 4 Code F | $36K1,026 at $35.38 | filing |
| 7 Jul 2026filed 13 Jul 2026 | BioLife SolutionsMedical Devices | SEC FORM 4 Code F | $23K844 at $27.79 | filing |
| 7 Jul 2026filed 13 Jul 2026 | BioLife SolutionsMedical Devices | SEC FORM 4 Code F | $23K844 at $27.79 | filing |
| 18 Jun 2026filed 22 Jun 2026 | BioLife SolutionsMedical Devices | SEC FORM 4 Code F | $24K937 at $26.04 | filing |
| 18 Jun 2026filed 22 Jun 2026 | BioLife SolutionsMedical Devices | SEC FORM 4 Code F | $24K937 at $26.04 | filing |
| 8 Jun 2026filed 10 Jun 2026 | BioLife SolutionsMedical Devices | SEC FORM 4 Code F | $27K1,026 at $26.10 | filing |
| 8 Jun 2026filed 10 Jun 2026 | BioLife SolutionsMedical Devices | SEC FORM 4 Code F | $27K1,026 at $26.10 | filing |
| 8 Apr 2026filed 10 Apr 2026 | BioLife SolutionsMedical Devices | SEC FORM 4 Code F | $16K844 at $19.27 | filing |
| 8 Apr 2026filed 10 Apr 2026 | BioLife SolutionsMedical Devices | SEC FORM 4 Code F | $16K844 at $19.27 | filing |
| 19 Mar 2026filed 23 Mar 2026 | BioLife SolutionsMedical Devices | SEC FORM 4 Code F | $72K3,749 at $19.12 | filing |
| 19 Mar 2026filed 23 Mar 2026 | BioLife SolutionsMedical Devices | SEC FORM 4 Code F | $72K3,749 at $19.12 | filing |
| 3 Mar 2026filed 5 Mar 2026 | BioLife SolutionsMedical Devices | SEC FORM 4 Sold | $12K588 at $20.74 | filing |
| 3 Mar 2026filed 5 Mar 2026 | BioLife SolutionsMedical Devices | SEC FORM 4 Sold | $12K588 at $20.74 | filing |
News
No headline names them, or the companies they trade most, lately.